211 related articles for article (PubMed ID: 35808990)
1. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging.
Mavrogeni S; Pepe A; Nijveldt R; Ntusi N; Sierra-Galan LM; Bratis K; Wei J; Mukherjee M; Markousis-Mavrogenis G; Gargani L; Sade LE; Ajmone-Marsan N; Seferovic P; Donal E; Nurmohamed M; Cerinic MM; Sfikakis P; Kitas G; Schwitter J; Lima JAC; Dawson D; Dweck M; Haugaa KH; Keenan N; Moon J; Stankovic I; Donal E; Cosyns B
Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):e308-e322. PubMed ID: 35808990
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases.
Mavrogeni SI; Markousis-Mavrogenis G; Koutsogeorgopoulou L; Dimitroulas T; Vartela V; Rigopoulos A; Noutsias M; Kolovou G
Heart Fail Rev; 2019 Jul; 24(4):489-498. PubMed ID: 30830518
[TBL] [Abstract][Full Text] [Related]
3. Myocardial Involvement in Rheumatic Disorders.
Markousis-Mavrogenis G; Pepe A; Gargani L; Kariki U; Bonou M; Koutsogeorgopoulou L; Manolopoulou D; Tektonidou MG; Vartela V; Kolovou G; Mavrogeni SI
Curr Heart Fail Rep; 2020 Oct; 17(5):171-180. PubMed ID: 32812180
[TBL] [Abstract][Full Text] [Related]
4. Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.
Mavrogeni SI; Sfikakis PP; Dimitroulas T; Koutsogeorgopoulou L; Katsifis G; Markousis-Mavrogenis G; Kolovou G; Kitas GD
Rheumatol Int; 2018 Jun; 38(6):949-958. PubMed ID: 29516170
[TBL] [Abstract][Full Text] [Related]
5. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases.
Mavrogeni SI; Sfikakis PP; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Dimitroulas T; Kolovou G; Kitas GD
JACC Cardiovasc Imaging; 2017 Nov; 10(11):1387-1396. PubMed ID: 29122140
[TBL] [Abstract][Full Text] [Related]
7. The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease.
Mavrogeni S; Markousis-Mavrogenis G; Kolovou G
BMC Cardiovasc Disord; 2016 Oct; 16(1):204. PubMed ID: 27793103
[TBL] [Abstract][Full Text] [Related]
8. Complementary role of cardiovascular imaging and laboratory indices in early detection of cardiovascular disease in systemic lupus erythematosus.
Mavrogeni S; Koutsogeorgopoulou L; Dimitroulas T; Markousis-Mavrogenis G; Kolovou G
Lupus; 2017 Mar; 26(3):227-236. PubMed ID: 27687024
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease in autoimmune rheumatic diseases.
Hollan I; Meroni PL; Ahearn JM; Cohen Tervaert JW; Curran S; Goodyear CS; Hestad KA; Kahaleh B; Riggio M; Shields K; Wasko MC
Autoimmun Rev; 2013 Aug; 12(10):1004-15. PubMed ID: 23541482
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular magnetic resonance for the evaluation of patients with cardiovascular disease: An overview of current indications, limitations, and procedures.
Mavrogeni SI; Kallifatidis A; Kourtidou S; Lama N; Christidi A; Detorakis E; Chatzantonis G; Vrachliotis T; Karamitsos T; Kouskouras K; Kelekis N
Hellenic J Cardiol; 2023; 70():53-64. PubMed ID: 36706867
[TBL] [Abstract][Full Text] [Related]
11. "Save the Last Dance" for Cardiovascular Magnetic Resonance.
Mavrogeni SI; Markousis-Mavrogenis G; Kolovou G
Eur Cardiol; 2018 Dec; 13(2):95-97. PubMed ID: 30697352
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular magnetic resonance in the diagnosis and management of cardiac and vascular involvement in the systemic vasculitides.
Mavrogeni SI; Dimitroulas T; Kitas GD
Curr Opin Rheumatol; 2019 Jan; 31(1):16-24. PubMed ID: 30407225
[TBL] [Abstract][Full Text] [Related]
13. Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases?
Mavrogeni S; Vassilopoulos D
Semin Arthritis Rheum; 2011 Dec; 41(3):488-96. PubMed ID: 21641017
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular involvement in pediatric systemic autoimmune diseases: the emerging role of noninvasive cardiovascular imaging.
Mavrogeni S; Servos G; Smerla R; Markousis-Mavrogenis G; Grigoriadou G; Kolovou G; Papadopoulos G
Inflamm Allergy Drug Targets; 2015; 13(6):371-81. PubMed ID: 25778740
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases.
Gulhane A; Ordovas K
Front Cardiovasc Med; 2023; 10():1215907. PubMed ID: 37808881
[TBL] [Abstract][Full Text] [Related]
16. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.
Lo Gullo A; Rodríguez-Carrio J; Gallizzi R; Imbalzano E; Squadrito G; Mandraffino G
Prog Cardiovasc Dis; 2020; 63(3):327-340. PubMed ID: 32201285
[TBL] [Abstract][Full Text] [Related]
17. Echocardiography in Autoimmune Rheumatic Diseases for Diagnosis and Prognosis of Cardiovascular Complications.
Makavos G; Varoudi M; Papangelopoulou K; Kapniari E; Plotas P; Ikonomidis I; Papadavid E
Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32883041
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases.
Markousis-Mavrogenis G; Sfikakis PP; Koutsogeorgopoulou L; Dimitroulas T; Katsifis G; Giannakopoulou A; Voulgari P; Kolovou G; Kitas GD; Mavrogeni SI
Mediterr J Rheumatol; 2021 Mar; 32(1):15-20. PubMed ID: 34386698
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
20. Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.
Mavrogeni SI; Sfikakis PP; Dimitroulas T; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Poulos G; Kolovou G; Theodorakis G; Kitas GD
Rheumatol Int; 2018 Sep; 38(9):1615-1621. PubMed ID: 30043238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
